Frequency of the Anti-Glutamic Acid Decarboxylase Immunological Marker in Patients With Diabetes Duration Longer Than Three Years in Southern Brazil

Sao Paulo Medical Journal - Brazil
doi 10.1590/s1516-31802011000300002
Full Text
Abstract

Available in full text

Categories
Medicine
Date
Authors
Publisher

FapUNIFESP (SciELO)

Related search

Diabetes Mellitus and Ataxia With Anti-Glutamic Acid Decarboxylase Antibodies

Endocrine Abstracts
2016English

Cerebellar Ataxia With Anti–Glutamic Acid Decarboxylase Antibodies

Archives of Neurology
2001English

The Role of Anti-Glutamic Acid Decarboxylase Autoantibodies in Mood Disorders

Neuroimmunology and Neuroinflammation
NeurologyImmunology
2015English

Clinical Characteristics of Anti-Glutamic Acid Decarboxylase Antibody-Positive Fulminant Type 1 Diabetes

Endocrine Journal
EndocrinologyMetabolismDiabetes
2019English

Cerebellar Ataxia Associated With Glutamic Acid Decarboxylase Autoantibody (Anti GAD)

Scholars Journal of Medical Case Reports
2020English

Anti–Glutamic Acid Decarboxylase Antibodies in the Serum and Cerebrospinal Fluid of Patients With Stiff-Person Syndrome

Archives of Neurology
2004English

Absence of Glutamic Acid Decarboxylase Antibodies in Pima Indian Children With Diabetes Mellitus

Diabetologia
Internal MedicineEndocrinologyMetabolismDiabetes
1999English

Effects of Anti-Glutamic Acid Decarboxylase Antibodies Associated With Neurological Diseases

Annals of Neurology
Neurology
2007English

Epilepsy and Cerebellar Ataxia Associated With Anti-Glutamic Acid Decarboxylase Antibodies

Journal of Neurology, Neurosurgery and Psychiatry
PsychiatryMental HealthNeurologySurgery
2007English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy